Back
Crinetics Pharmaceuticals Stock Predictions
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
48
CRNX
Crinetics Pharmaceuticals
Last Price:
53.50
Seasonality Move:
3%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Crinetics Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 17.4% based on the past 6 years of stock performance.
- Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Crinetics Pharmaceuticals Stock Undervalued?
The current Crinetics Pharmaceuticals [CRNX] share price is $53.91. The Score for CRNX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal. - CRNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Crinetics Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 17.4% based on the past 6 years of stock performance.
Crinetics Pharmaceuticals Stock Rating
Sell
48
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals overpriced?
- Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Crinetics Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crinetics.com
52-Week Data
52-Week High:
55.78
52-Week Low:
25.35
Prediction Charts
Market Cap:
4.31B
Price in USD:
53.91
Volume:
574.55K
Beta:
0.69
Technical Analysis
SMA50:
52.41
SMA100:
49.55
SMA200:
44.49
52-Wk Change:
83.43%
Stock Predictions
-
Is Crinetics Pharmaceuticals stock public?
Yes, Crinetics Pharmaceuticals is a publicly traded company. -
What is the Crinetics Pharmaceuticals stock quote today?
The Crinetics Pharmaceuticals stock price is 53.91 USD today. -
How to buy Crinetics Pharmaceuticals stock online?
You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-30 | 53.00 | 53.02 | 53.48 | 52.04 |
| Sep-3 | 53.24 | 52.02 | 54.12 | 51.32 |
| Sep-4 | 51.86 | 52.80 | 53.29 | 51.21 |
| Sep-5 | 53.07 | 50.98 | 53.42 | 50.70 |
| Sep-6 | 51.26 | 50.34 | 51.66 | 49.67 |
| Sep-9 | 51.06 | 52.19 | 53.12 | 50.66 |
| Sep-10 | 52.00 | 50.40 | 52.27 | 49.93 |
| Sep-11 | 50.60 | 50.76 | 51.38 | 50.05 |
| Sep-12 | 50.50 | 51.26 | 51.59 | 49.96 |
| Sep-13 | 52.01 | 53.80 | 53.85 | 51.59 |
| Sep-16 | 53.90 | 53.94 | 54.51 | 53.32 |
| Sep-17 | 54.11 | 52.99 | 54.31 | 52.30 |
| Sep-18 | 53.24 | 52.77 | 53.90 | 52.07 |
| Sep-19 | 54.02 | 53.91 | 55.16 | 53.29 |
Crinetics Pharmaceuticals Earnings
Crinetics Pharmaceuticals Earnings Report: Per Share Crinetics Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Crinetics Pharmaceuticals Forecast Revenue Growth
Crinetics Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.25 per share.
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.